Order a Free Summer Safety Kit
Keep your summer safe and healthy with a free publication kit that includes tips from the U.S. Food and Drug Administration, Consumer Product Safety Commission, and Centers for Disease Control and Prevention. Learn how to better manage your medicines and vitamins, plan safe cookouts, prevent mosquito bites, and protect children and guests in the home and at the pool.
The FDA Warns Against Using Unapproved Versions of Juvederm
The FDA updated its Dermal Fillers (Soft Tissue Fillers) website to warn the public about unapproved versions of Juvederm, such as Juvederm Ultra 2, 3, or 4, which are being sold and distributed illegally in the U.S.
Lupin Pharmaceuticals Inc. announced a recall of lot L600518, Exp 05/18 of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1 mg/0.02 mg chewable and ferrous fumarate 75 mg) Tablets at the consumer level. A confirmed market complaint indicated a packaging error, where the blister was rotated 180 degrees within the wallet, reversing the weekly tablet orientation and making the lot number and expiration date no longer visible. The first four days of therapy would have had four non-hormonal placebo tablets as opposed to the active tablets.
Consumers who have the affected product should notify their physician and return the product to the pharmacy or place of purchase and contact their physician or healthcare provider if they have experienced any problems that may be related to taking this drug product.
The FDA continues to have an important role in addressing the epidemic of opioid addiction. FDA Commissioner, Scott Gottlieb, M.D., shares his first steps toward reducing the epidemic’s scope in his first FDA Voice blog.
No hay comentarios:
Publicar un comentario